Stocks

Crown Castle reported lower tower revenue and EBITDA, but AFFO rose 8% as lower interest costs supported results and management raised its outlook.

Sharron Kendi · Oct 25, 22:30

ANI Pharmaceuticals reports third-quarter results November 5. Investors will watch Cortrophin growth, rare-disease momentum and full-year guidance.

Elsy kanana · Oct 25, 20:00

Reliance posted record third-quarter sales of $5.21 billion and adjusted EPS of $8.02 as metals demand, pricing and project shipments strengthened.

Sharron Kendi · Oct 25, 19:30

PG&E reported lower third-quarter earnings but maintained its 2026 and 2027 core EPS guidance while reducing planned 2027 capital spending.

Elsy kanana · Oct 25, 19:00

Texas Instruments posted 28% revenue growth, a 78% profit increase and stronger free cash flow while setting a higher fourth-quarter range.

Sharron Kendi · Oct 25, 18:30

AMD earnings preview: Data Center growth, AI accelerator demand, gross margin and second-half guidance lead the November 3 investor watchlist.

Elsy kanana · Oct 25, 17:00

Visa earnings preview: Payment volumes, cross-border growth, client incentives and fiscal 2027 guidance lead the October 27 investor watchlist.

Sharron Kendi · Oct 25, 16:30

Ford earnings preview: Q3 sales, margins, EV losses, cash flow and updated 2026 guidance lead the watchlist before the October 28 report.

Sharron Kendi · Oct 25, 15:30

Chevron reports October 30. Oil prices, refining margins, production, portfolio integration and capital returns lead the investor watchlist.

Elsy kanana · Oct 25, 15:00

Regeneron reports October 30. Dupixent growth, EYLEA HD momentum, margins and updated 2026 guidance lead the investor watchlist.

Sharron Kendi · Oct 25, 14:30